3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasms
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
8
Mycophenolic Acid
6
Whole-Body Irradiation
5
Busulfan
5
fludarabine phosphate
4
fludarabine
4
Tacrolimus
4
Cyclosporine
4
Rituximab
3
Etoposide
3
Cytarabine
3
venetoclax
2
ruxolitinib
2
pegfilgrastim
2
blinatumomab
2
asciminib
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Inotuzumab Ozogamicin
2
Filgrastim
2
tocilizumab
1
ricolinostat
1
rasburicase
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor, human
1
nilotinib
1
idelalisib
1
ibrutinib
1
ceralasertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Tyrosine Kinase Inhibitors
×
30 days
×
Clear all
No trials found.